NTRK Fusion Testing & Diagnosis
Biomarker ‘genomic testing’ offers a gateway to better understand our type of cancer.
Testing the tumor for genetic changes is the only way to detect cancer drivers like NTRK gene fusions.
Genomic testing involves sending a tissue sample of the tumor or a circulating blood test (cfDNA) to a laboratory for DNA sequencing. The lab searches for specific abnormalities and changes in the cancer cells before returning results to your care team. If the test result is positive for NTRK gene fusions or another known cancer driver, the information may help to identify treatment and clinical research options.